Profil
Carolyn McAuliffe is currently working as a Senior Director-Communications at Aerie Pharmaceuticals, Inc. since 2021.
Prior to this, she worked as Head-Communications at Masimo Corp.
Postes actifs de Carolyn McAuliffe
| Sociétés | Poste | Début |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Public Communications Contact | 13/09/2021 |
Anciens postes connus de Carolyn McAuliffe
| Sociétés | Poste | Fin |
|---|---|---|
| MASIMO CORPORATION | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MASIMO CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |